CAS 339086-79-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Rovelizumab
CAS :Humanized whole monoclonal antibody targeting CD11 and CD18; designed to treat haemorrhagic shockRovelizumab
CAS :Rovelizumab: humanized anti-CD11/CD18 antibody for MS, hemorrhagic shock, MI, and stroke research.Degré de pureté :95% - 95%Couleur et forme :Liquid
